GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Deccan Health Care Ltd (BOM:542248) » Definitions » Debt-to-EBITDA

Deccan Health Care (BOM:542248) Debt-to-EBITDA : 0.45 (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Deccan Health Care Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Deccan Health Care's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹2.3 Mil. Deccan Health Care's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹14.4 Mil. Deccan Health Care's annualized EBITDA for the quarter that ended in Sep. 2023 was ₹37.1 Mil. Deccan Health Care's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was 0.45.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Deccan Health Care's Debt-to-EBITDA or its related term are showing as below:

BOM:542248' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.08   Med: 0.58   Max: 2.26
Current: 0.68

During the past 8 years, the highest Debt-to-EBITDA Ratio of Deccan Health Care was 2.26. The lowest was 0.08. And the median was 0.58.

BOM:542248's Debt-to-EBITDA is ranked better than
68.08% of 661 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs BOM:542248: 0.68

Deccan Health Care Debt-to-EBITDA Historical Data

The historical data trend for Deccan Health Care's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deccan Health Care Debt-to-EBITDA Chart

Deccan Health Care Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial 0.08 0.11 0.50 0.58 0.58

Deccan Health Care Semi-Annual Data
Mar16 Mar17 Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 -2.42 0.29 0.96 0.45

Competitive Comparison of Deccan Health Care's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Deccan Health Care's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deccan Health Care's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Deccan Health Care's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Deccan Health Care's Debt-to-EBITDA falls into.



Deccan Health Care Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Deccan Health Care's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 11.88) / 20.543
=0.58

Deccan Health Care's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.274 + 14.422) / 37.14
=0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2023) EBITDA data.


Deccan Health Care  (BOM:542248) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Deccan Health Care Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Deccan Health Care's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Deccan Health Care (BOM:542248) Business Description

Traded in Other Exchanges
N/A
Address
H.No. 6-3-348/4, Dwarakapuri Colony, Punjagutta, Hyderabad, TG, IND, 500082
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products including nutraceutical, cosmeceutical, and ayurveda products ( Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The company operates in India as well as exports its products to other countries and the maximum of its revenue comes from India.

Deccan Health Care (BOM:542248) Headlines

No Headlines